A detailed history of Warren Averett Asset Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 47,838 shares of DXCM stock, worth $2.78 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
47,838
Previous 3,049 1468.97%
Holding current value
$2.78 Million
Previous $266,000 1110.15%
% of portfolio
0.03%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$66.46 - $89.53 $2.98 Million - $4.01 Million
44,789 Added 1468.97%
47,838 $3.22 Million
Q2 2025

Aug 14, 2025

SELL
$59.83 - $87.57 $2,034 - $2,977
-34 Reduced 1.1%
3,049 $266,000
Q1 2025

May 15, 2025

SELL
$67.74 - $90.75 $16,054 - $21,507
-237 Reduced 7.14%
3,083 $210,000
Q4 2024

Feb 14, 2025

BUY
$65.68 - $81.01 $218,057 - $268,953
3,320 New
3,320 $258,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Warren Averett Asset Management, LLC Portfolio

Follow Warren Averett Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warren Averett Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warren Averett Asset Management, LLC with notifications on news.